NEW YORK, June 13, 2016 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a global investor rights law firm, reminds investors that August 8, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Chiasma, Inc. (“Chiasma” or “Company”) (NASDAQ:CHMA) and certain of its directors (collectively, “Defendants”). Chiasma investors are encouraged to go to: http://www.scott-scott.com/cases/new/securities-fraud-litigation-2899-chiasma-inc-chma.html. You can also contact Joseph Halloran at (646) 582-0121, or e-mail jhalloran@scott-scott.com for information.
Chiasma is a late-stage biopharmaceutical company that focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Chiasma was founded in 2001, and is headquartered in Newton, Massachusetts. Chiasma’s lead product candidate is oral octreotide, or Mycapssa, for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone.
The complaint alleges that between July 15, 2015 and April 17, 2016, inclusive (the “Class Period”), Defendants made false and/or misleading statements and/or failed to disclose that: (i) Chiasma’s Phase 3 clinical trial methodology for Mycapssa was not sufficient to demonstrate efficacy and secure FDA approval; (ii) Chiasma’s supervision of its suppliers was not sufficient to prevent deficiencies that would delay FDA approval of Mycapssa; and (iii) as a result of the foregoing, Chiasma’s public statements were materially false and misleading at all relevant times.
What You Can Do
If you purchased shares of Chiasma stock, you may have legal claims against the Company. If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact attorney Joseph Halloran at (800) 404-7770 or (646) 582-0121, or at jhalloran@scott-scott.com.
About Scott + Scott, Attorneys at Law, LLP
Scott+Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm has offices in New York, London, Connecticut, California, and Ohio. Please visit www.scott-scott.com for more information about the firm.